Danaher shares slide after knockout quarter. Here’s why it’s a buying opportunity

A health worker processes a Covid-19 antibody test for a patient at the Diagnostic and Wellness Center in Torrance, California, on May 5, 2020.

Valerie Macon | AFP | Getty Images

Danaher (DHR) reported better-than-expected earnings for the third quarter, as all three segments of the health technology company posted strong earnings.


Leave a Comment

Your email address will not be published.